Phio Pharmaceuticals announced its INTASYL platform will be the focus of Viewpoint, a national program hosted by Dennis Quaid. The program will air in April on PBS stations across the country.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHIO:
- National Spotlight Features Phio’s Innovative RNAi Technology Platform
- Phio Pharmaceuticals on the Brink: Nasdaq Delisting Looms Over Falling Stock Prices
- Phio Pharmaceuticals reports FY23 EPS ($5.20) vs ($10.10) last year
- Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update
- Phio Pharmaceuticals presents data about INTASYL